ProCE Banner Activity

Applying Lessons and Experience in Pediatric Patients to the Treatment of AYA and Adult Patients With ALL

Slideset Download
Download this slideset from a live CCO symposium for an expert overview on applying pediatric ALL regimens to the treatment of AYA and adult patients with ALL.

Released: June 06, 2022

Expiration: June 05, 2023

No longer available for credit.

Share

Faculty

Daniel J. DeAngelo

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Jazz Pharmaceuticals Inc

Program Director Disclosure

Program Director

Daniel J. DeAngelo, MD, PhD

Chief, Division of Leukemia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Daniel J. DeAngelo, MD, PhD, has disclosed that he has received funds for research support from AbbVie, Blueprint, GlycoMimetics, and Novartis; received consultant/advisor/speaker fees from AbbVie, Agios, Amgen, Autolus, Blueprint, Forty-Seven, Gilead, GlycoMimetics, Incyte, Jazz, Kite, Novartis, Pfizer, Servier, and Takeda; and was on the DSMB for Daiichi-Sanko and Fibrogen.